CHIMERIC ANTIGEN RECEPTOR CELLS FOR TREATING SOLID TUMOR

• 1. 用于治疗实体瘤的嵌合抗原受体细胞 [P] . 中国专利： CN112638947A . 2021-04-09
• 2. 用于治疗血液癌症和实体瘤癌症的嵌合抗原受体修饰的T细胞(CAR-T) [P] . 中国专利： CN113710688A . 2021-11-26
• 3. Chimeric antigen receptor cells for treating solid tumors [P] . JP2022500011A . 2022-01-04

  机译： 用于治疗实体瘤的嵌合抗原受体细胞

• 4. CHIMERIC ANTIGEN RECEPTOR CELLS FOR TREATING SOLID TUMOR [P] . EP3847195A1 . 2021-07-14

  机译： 用于治疗实体瘤的嵌合抗原受体细胞

• 5. Chimeric antigen receptor cells for treating solid tumor [P] . US11161913B2 . 2021-11-02

  机译： 用于治疗实体瘤的嵌合抗原受体细胞

• 1. T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo [J] . Xiaojun Tang, Yan Zhou, Wenjie Li, 生物医学研究杂志（英文版） . 2014,第006期
• 2. T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo [J] . Xiaojun Tang, Yan Zhou, Wenjie Li, 生物医学研究杂志：英文版 . 2014,第006期
• 3. Tumor Antigen Specific Activation of Primary Human T-Cells Expressing a Virally Encoded Chimeric T-Cell Receptor Specific for p185HER2 [J] . 杨建民, MichaelSFRIEDMAN, ChristopherMREYNOLDS, 中华微生物学和免疫学：英文版 . 2004,第004期
• 4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020
• 5. Optimizing Chimeric Antigen Receptor (CAR) T Cells for an Enhanced and Broadened Anti-Tumor Immune Response Via Il-36γ [D] . Li, Xinghuo. 2020
• 6. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models [O] . Baozhu Huang, Liqun Luo, Jun Wang, 2020
• 7. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting [O] . Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, 2016

• 1. Programmed cell death protein-1 inhibitor combined with chimeric antigen receptor T cells in the treatment of relapsed refractory non- Hodgkin lymphoma: A case report [J] . Zhi-Yun Niu ,Li Sun ,Shu-Peng Wen . 世界临床病例杂志 . 2021,第010期
• 2. Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma [J] . Kai Dai ,Yin Wu ,Sha She . 世界胃肠肿瘤学杂志:英文版(电子版) . 2021,第12期
• 3. 嵌合抗原受体T细胞治疗B细胞淋巴瘤-单中心经验分享 [C] . 肖霞 ,江嫣雨 ,李青 . 世界中医药学会联合会血液病专业委员会第三届学术年会暨天津中西医结合学会血液病专业委员会2018学术年会 . 2018
• 4. 应用嵌合性抗原受体T细胞过继性治疗实体瘤的临床前研究 [A] . 韩雅丽 . 2018